Kansas SB 41: Establishing a $100 maximum out-of-pocket cost-share per month per covered person for prescription insulin drugs.

Status: Died in Committee (as of 2022-05-23)

State: Kansas · Session: 2021-2022 · Bill: SB 41

Sponsors: Committee on Federal and State Affairs

View Kansas SB 41 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.